Khwarizm International Medical Studies Private Limited - Company Profile

It is a business services private limited company based in New Delhi, Delhi, India, established in 2025.
2025 New Delhi, Delhi, India Active
Last Updated:
About Khwarizm International Medical Studies Private Limited

Khwarizm International Medical Studies Private Limited, a active private limited company, was established on 06 September 2025 in New Delhi, Delhi, India. it holds CIN: U85500DL2025PTC454800. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Formerly known as Khwarizm International Medical Studies Private Limited. Its leadership includes Syed Tafiq Sarfraz (Director), Syed Faisal Tanvir (Director), Shah Shaja Ulhaq (Managing Director). It is based at G-4, Ground Floor S 522, School Block Shakarpur, New Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85500DL2025PTC454800

  • Registration Number

    454800

  • Incorporation Date

    06 September 2025

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Months 22 Days
Company report

Khwarizm International Medical Studies Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Khwarizm International Medical Studies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Khwarizm International Medical Studies Private Limited?
Current Directors
Name Designation Appointment Date Status
Syed Tafiq Sarfraz Director 06 Sep 2025 Current
Syed Faisal Tanvir Director 06 Sep 2025 Current
Shah Shaja Ulhaq Managing Director 06 Sep 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Khwarizm International Medical Studies.
Khwarizm International Medical Studies revenue growth over time
Khwarizm International Medical Studies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Khwarizm International Medical Studies?

Unlock access to Khwarizm International Medical Studies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Khwarizm International Medical Studies?

Unlock and access historical data on people associated with Khwarizm International Medical Studies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Khwarizm International Medical Studies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Khwarizm International Medical Studies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Khwarizm International Medical Studies
Recent Activity within the Organization
  • Director Appointment

    The activity Syed Tafiq Sarfraz was appointed as a Director was appointed as a Director on 06 Sep 2025 & has been associated with this company since 5 months 22 days . was completed.

  • Director Appointment

    Progress on Syed Faisal Tanvir was appointed as a Director was appointed as a Director on 06 Sep 2025 & has been associated with this company since 5 months 22 days . was documented.

  • Director Appointment

    Progress on Shah Shaja Ulhaq was appointed as a Managing Director was appointed as a Managing Director on 06 Sep 2025 & has been associated with this company since 5 months 22 days . was documented.

  • Company Incorporation

    Progress on Khwarizm International Medical Studies Private Limited was registered on 06 Sep 2025 with Roc Delhi & aged 5 months 22 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Khwarizm International Medical Studies Private Limited?

The CIN of Khwarizm International Medical Studies Private Limited is U85500DL2025PTC454800.

Where is Khwarizm International Medical Studies Private Limited headquartered?

Khwarizm International Medical Studies Private Limited is headquartered at G-4, Ground Floor S 522, School Block Shakarpur, New Delhi, Delhi, 110092.

When was Khwarizm International Medical Studies Private Limited incorporated?

Khwarizm International Medical Studies Private Limited was incorporated on 06 September 2025.

Who are the current directors of Khwarizm International Medical Studies Private Limited?

The current directors of Khwarizm International Medical Studies Private Limited are

Is Khwarizm International Medical Studies Private Limited a listed company?

Khwarizm International Medical Studies Private Limited is unlisted.

What is the capital structure of Khwarizm International Medical Studies Private Limited?

The authorized capital of Khwarizm International Medical Studies Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available